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Abstract
Pseudomonas aeruginosa, the leading cause of morbidity and mortality in people with cystic fibrosis (CF), adapts for survival
in the CF lung through both mutation and gene expression changes. Frequent clonal strains such as the Australian Epidemic
Strain-1 (AES-1), have increased ability to establish infection in the CF lung and to superimpose and replace infrequent
clonal strains. Little is known about the factors underpinning these properties. Analysis has been hampered by lack of
expression array templates containing CF-strain specific genes. We sequenced the genome of an acute infection AES-1
isolate from a CF infant (AES-1R) and constructed a non-redundant micro-array (PANarray) comprising AES-1R and seven
other sequenced P. aeruginosa genomes. The unclosed AES-1R genome comprised 6.254Mbp and contained 6957 putative
genes, including 338 not found in the other seven genomes. The PANarray contained 12,543 gene probe spots; comprising
12,147 P. aeruginosa gene probes, 326 quality-control probes and 70 probes for non-P. aeruginosa genes, including phage
and plant genes. We grew AES-1R and its isogenic pair AES-1M, taken from the same patient 10.5 years later and not
eradicated in the intervening period, in our validated artificial sputum medium (ASMDM) and used the PANarray to compare
gene expression of both in duplicate. 675 genes were differentially expressed between the isogenic pairs, including
upregulation of alginate, biofilm, persistence genes and virulence-related genes such as dihydroorotase, uridylate kinase
and cardiolipin synthase, in AES-1M. Non-PAO1 genes upregulated in AES-1M included pathogenesis-related (PAGI-5) genes
present in strains PACS2 and PA7, and numerous phage genes. Elucidation of these genes’ roles could lead to targeted
treatment strategies for chronically infected CF patients.
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Introduction
In cystic fibrosis (CF) patients, chronic Pseudomonas aeruginosa
infection and inflammation are associated with biofilm formation,
a progressive decline in lung function and premature death [1,2,3].
Early infection of CF infants with P. aeruginosa is usually
successfully managed by aggressive antibiotic therapy; however
by adolescence most patients have chronic infection. Prominent
persisters include the frequent clones Liverpool Epidemic Strain
(LES), Manchester strain (c3719), and the Australian Epidemic
Strain-1 (AES-1), which infects ca. 40% of adult CF patients in
Sydney and Melbourne [4,5]. While frequent clones are often
more resistant to antibiotics than infrequent clones, they lack a
distinctive antibiotic resistance profile [6], indicating that other
factors are involved in their persistence.
P. aeruginosa undergo a number of genetic and expression
changes that assist in their ability to survive in the CF lung and to
evade detection and clearance by the immune system [7,8]. Acute
lung infection in CF patients is associated with expression of
virulence determinants that are involved in establishment of
infection in animal model systems [9,10,11,12]. However, P.
aeruginosa from chronically-infected CF patients usually lack some
of these virulence determinants, suggesting that these genes are
unnecessary for long-term maintenance of P. aeruginosa infection in
vivo [13,14,15].
Genomic studies of two closely related P. aeruginosa strains
collected from a CF patient 7.5 years apart [14] showed loss of
function mutations in virulence genes required for O-antigen
biosynthesis, Type III secretion (T3SS), twitching motility,
exotoxin A regulation, multidrug efflux, osmotic balance,
phenazine biosynthesis, quorum sensing, and iron acquisition.
Chronic infection strains also possess particular characteristics,
including large chromosomal inversions (LCI) [16], a specific Type
IV pilin allele [17], exhibit enhanced biofilm dispersal properties
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vivo conditions can also result in genomic changes to persistent
strains and this is probably related to strain hypermutability
[20,21].
Persistence may also be related to changes in levels of expression
of particular genes. Conversion to the mucoid phenotype, which is
dependent on biofilm formation, has been associated with
establishment ofchronic infection [22]. Chronic growth also appears
to activate new virulence strategies, including the catabolism of fatty
acids such as phosphotidylcholine and prostaglandin, thus prevent-
ing their utilisation by the host [12]. A study of sequential isogenic P.
aeruginosa isolates from three adults with chronic infection showed
upregulation of anaerobic respiration, microaerobic respiration and
the TCA cycle pathways [23], however there have been no studies
comparing the gene expression changes between isogenic acute
infection and chronic infection isolates. Additionally, the sequencing
of the acute AES-1 isolate AES-1R and the use of an array
encompassing eight P. aeruginosa genomes has allowed detection of
novel genes not present in the PAO1 genome.
This study has used an artificial sputum media closely
mimicking CF sputum (ASMDM) [24] and an array based on
the genome sequence of AES-1R and other CF isolates
(PANarray) to identify the gene expression changes in sequential
early and chronic isogenic AES-1 isolates.
Results
Homology between AES-1 and other P. aeruginosa
genomes
In order to identify all coding sequences (CDS) in the eight P.
aeruginosa genomes (AES-1, PAO1, PA7/PSPA7, PA14, PACS2,
Pa_2192, Pae/PALES and c3719), BLAST analysis was per-
formed on the AES-1R sequence, which produced 7672 clusters,
of which 3962 represented CDS common to all strains, while
between 54 and 338 CDS were unique to one of the eight
genomes, based on an E-value of less than 10
24 (Table 1). The
AES-1R genome comprised 6,254,604 bases, the second smallest
genome on the PANarray after c3719. Overall 7199 putative CDS
were detected, which after the elimination of 242 adjoining
duplicates gave an adjusted total of 6957 CDS. This is higher than
the average for the seven other PANarray genomes (5784) though
the number might fall if the genome sequence is closed, as other
genes may have been duplicated. The predicted subcellular
location of CDS products (Fig. 1) showed that AES-1R has a
significantly lower proportion of cytoplasmic proteins (39.7%) than
the genomes of PACS2 (41.8%), PAO1 (41.8%) and c3719
(41.4%), (Pearson’s x
2 test: p=0.0014, p=0.017 and p=0.047,
respectively,). In terms of cluster of orthologous groups (COG)
function (not shown), a comparison of AES-1R with PAO1, PA14,
Pa2192 and PA7 showed no significant differences in group size
(p,0.05) with the exception of inorganic ion transport and
metabolism, where AES-1R had a significantly greater number of
CDS (388 against 291) compared to PA7 (p=0.035).
AES-1R had the highest number of unique CDS of the eight
genomes (338), though as a percentage of total CDS, AES-1 was at
the same level as P. aeruginosa Pa2192 (Table 1). The unique AES-
1R genes coded mainly for hypothetical proteins, but also included
several characterized proteins such as the SOS-response tran-
scriptional repressor lexA (AES_7031), three Mu-like bacterio-
phages (AES_7010, 7011 and 7084), the bacteriophage P2 tail
protein gpl, heme exporter protein ccmA and polyhydroxyalkanoate
synthesis protein phaF (Table S1). Fully 67.4% of CDS in the
region between AES_6966 and AES_7152 are unique to AES-1R
(E value less than 10
,4 for all homologs), indicating that this 187
CDS region may be part of the AES-1R accessory genome. While
most CDS in this region are hypothetical proteins, 16 have
putative or probable phage functions.
Genotyping and growth characteristics of CF strains in
ASMDM
Pulsed field gel electrophoresis (PFGE) of AES-1R and AES-1M
showed no discernable band differences (Fig. 2) therefore they
were classed as the same strain. The acute and chronic isolates
both had a non-mucoid phenotype on horse blood agar (HBA) and
Mueller-Hinton agar (MHA). This is unusual since most chronic
isolates are mucoid or revertants from mucoid phenotypes [25,26].
AES-1R and AES-1M may qualify as small colony variants (SCV)
due to their small colony size of 2–5 mm after 48 hours, and the
upregulation of the polysaccharide genes pelC and pelE, part of the
pelABCDEF in AES-1M may be contributing to this morphotype
(see Discussion) [27]. As shown in Fig. 3, there is a difference in the
growth patterns of AES-1R and AES-1M. AES-1R grew with a
thickened pellicle and projections into the media while AES-1M
had smaller projections at 72h. When incubated for up to 96h, the
growth of AES-1M resembled that of AES-1R (not shown),
indicating that it is slower growing during chronic infection. The
growth characteristics of AES-1M resembled those of P. aeruginosa
UCBPP-PA14 in ASMDM [24], which also grew more slowly with
smaller anaerobic projections.
Table 1. Genomic statistics of the P. aeruginosa genomes on the PANarray.
Bacterial strain Size (Mbp) Total CDS1 Unique CDS % of genome
P. aeruginosa AES-1R 6.254 6957{ 338 4.9%
P. aeruginosa Pa2192 6.826 5914 284 4.8%
P. aeruginosa PACS2 6.492 5676 44 0.8%
P. aeruginosa UCBPP-PA14 6.537 5896 183 3.1%
P. aeruginosa PAO1 6.264 5568 73 1.3%
P. aeruginosa c3719 6.146 5221 63 1.2%
P. aeruginosa PaLES 6.601 5925 193 3.3%
P. aeruginosa PSPA7 6.439 6286 54 0.9%
1CDS = Coding sequences.
{Total adjusted for adjoining duplicates.
All genes were annotated based on BLAST analysis results, with genes showing an E-value of less than 10
24 designated as unique.
doi:10.1371/journal.pone.0024526.t001
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In all, 675 genes were differentially-expressed between the
frequent clone isolates AES-1R and AES-1M at p,0.05 (Table
S2) including 365 upregulated and 310 downregulated in the
chronic AES-1M. Five hundred and twenty five of these genes
were differentially expressed $2fold, while 74 (11.2%) of all
differentially expressed genes did not have homologues in the
PAO1 genome sequence (Table S3). These genes would not have
been detectable on the Affymetrix PAO1 array. They included 10
phage genes and one integrase gene, eight of which were
upregulated (average upregulation 3.7fold), two upregulated
pathogenesis-related proteins from P. aeruginosa gene island-5
(PAGI-5): PaerPA_01000873 (3.8fold) and PSPA7_4490 (5.8fold),
the enzyme uridylate kinase (6.4fold), and the downregulated
proteins polyketide synthase (24.3fold) and luminal binding
protein (23.4fold).
Gene expression differences between acute and chronic
infection AES-1 isolates
Against expectations that chronic infection leads to a downreg-
ulation of virulence-related genes, a number of genes with
virulence functions were upregulated in chronic AES-1M
compared to its acute infection counterpart (Table 2). These
included alcohol dehydrogenase adhA, (5.5fold), the T3SS
regulator pscD (3.2fold), uroporphyrinogen decarboxylase hemE
(16-fold), peptidyl-prolyl cis-trans isomerase ppiA (2.5-fold), algi-
nate-associated genes algD,E,F,8 and amrZ (1.9 to 10.7fold),
dihydroorotase pyrC (12.1fold), uridylate kinase pyrH (6.4fold),
the extracellular polysaccharide genes pelC (5.6fold) and pelE
(3.7fold) part of the pelABCDEF operon, phospholipase N (plcN)
(3.2fold) and cardiolipin synthase cls (7.0fold). Genes with putative
or probable virulence roles upregulated in chronic AES-1M
included a probable haloacid dehalogenase (21.6fold), threonine
dehydratase ilvA1 (9.7fold) xanthine phosphoribosyltransferase xpt
(16.7fold) and polyhydroxyalkanoate synthesis protein phaF
(6.0fold) (Table S2). The downregulation of homogentisate 1,2-
dioxygenase hmgA (-7.5fold) is also virulence related since its
downregulation de-represses pyomelanin production, which en-
hances persistence.
Gene expression by quantitative PCR
The average quantitative PCR ratios of the selected virulence-
related (Table 2) and other genes correlated well with their
microarray expression ratios (correlation coefficient: R
2=0.8053
2 Fig. 4). All genes showed either up- or downregulation
consistent with the microarray results, despite eight of these being
quantified using different RNA samples for array and qPCR.
Discussion
The sequencing of the genome of the Australian epidemic strain
AES-1 (isolate R) has provided the first opportunity to examine the
similarities and differences between this frequent clone widespread
in eastern Australia and other frequent clones such as PaLES and
c3719. In terms of overall size, AES-1R (6.254 Mbp) falls between
c3719 (6.146 Mbp) and PaLES (6.601 Mbp), and close to that of
PAO1 (6.264 Mbp). As the c3719 and PaLES genomes are closed
and the AES-1R genome is not, a direct comparison of CDS is not
possible, however in terms of genes of known function there are
significant differences between AES-1R and c3719. In subcellular
localisation (Fig. 1) AES-1R has a significantly smaller proportion
of cytoplasmic genes and a significantly greater proportion (3.4%
against 2.7%) of outer membrane genes compared to c3719
Figure 1. Subcellular localization of P. aeruginosa AES-1R genes with known functions. Gene products of known function were classified
into one of six localization sites (cytoplasmic-CYT, inner membrane-IM, outer membrane-OM, exomembrane-ExM, periplasmic-PER, secreted-sec) for
each of the eight P. aeruginosa genomes on the PANarray. AES-1R had a significantly lower cytoplasmic protein content (39.7%) compared to PACS2
(41.8%), PAO1 (41.8%) and c3719 (41.4%) (Pearson’s x
2 test: p=0.0014, p=0.017 and p=0.047, respectively).
doi:10.1371/journal.pone.0024526.g001
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2 test: p=0.047 and p=0.019, respectively,). With
respect to unique CDS (Table 1), PaLES (3.3%) and c3719 (1.2%)
have significantly smaller proportions compared to total CDS than
does AES-1R (p,0.0001 for both comparisons). The proportion of
unique CDS in AES-1R is similar to that for Pa2192 (p=0.83).
The 338 unique CDS (Table S1) are heavily concentrated between
AES_6966 and AES_7152, thus there is a high likelihood that this
187-CDS region represents a portion of the AES-1R accessory
genome. AES-1R contains at least one novel integrated prophage
in this region, with 16 CDS having a known or putative phage
function. Amongst these are two Mu-like prophage proteins (gp28
and gp29). Mu-like proteins have been identified in a number of
pathogenic bacteria including Haemophilus ducreyi, Shigella sonnei,
Escherichia coli 0157:H7, Bordetella bronchiseptica and the Pseudomo-
nas-related species Burkholderia cenocepacia [28]. Prophages have
been identified in LES [29] and c3719 genomes [30], however
BLAST searches of genes from the AES-1R prophage failed to
identify homologs in these epidemic strains. There was no
discernable pattern of differential expression by genes in this
putative accessory region in the AES-1R/1M array comparison
conducted in this study. However the upregulation of two non-
PAO1 genes belonging to PAGI-5 is interesting as it links AES-1R
to the pathogenic features of this gene island found in PA7 and
PACS2. PAGI-5-containing strains have been shown to be more
virulent than non-PAGI-5 strains in mammalian models [31].
A majorobjective of thisstudywasto utilize theAES-1Rsequence
and the PANarray to elucidate the differences and similarities in
gene expression between the acute and chronic isolates of AES-1.
The finding that certain virulence-related genes were upregulated in
chronic infection isolate AES-1M has relevance in areas including
biofilm development, transmissibility, antibiotic resistance, pyome-
lanin-related persistence and lung surfactant secretion (Table 2). The
upregulation of adhA is required for P. aeruginosa biofilm development
[32] and biofilms are important in virulence and persistence. We
previously reported that AES-1 strains produce significantly larger
biofilms than non-epidemic strains [33] thus the upregulated
expression of biofilm-related genes in AES-1M would enhance its
ability to persist. T3SS genes are generally switched off or
downregulated at chronic infection and several including pcrV, pscC
and pscI weresignificantlydownregulated inAES-1M;howeverpscD,
a regulatory T3SS gene [34] was significantly upregulated in AES-
1M. As a functioning regulator, pscD may trigger the T3SS and
enable AES-1M to infect other CF patients from the environment or
transmit to other patients via aerosols from an infected patient. ppiA
is one of four periplasmic isomerases in E. coli, inactivation of which
leads to a decreased growth rate and increased susceptibility to
certain antibiotics [35]. It has been shown in E. coli that hemE is the
first enzyme transcribed in heme synthesis, and heme synthesis gene
expression has been linked to regulation of alginate secretion [36].
While AES-1M appeared non-mucoid on HBA and MHA (see
Results), there was significant upregulation of most alginate genes in
ASMDM, suggesting that this mucus-like medium triggers their
enhanced expression. Alginate is considered a chronic infection
virulence factor [12] and is involved in biofilm production and
resistance to leukocyte killing [37]. The exception was a significant
downregulation of algC in AES-1M. algC is transcribed separately
from theother alginate genes, which areina singleoperon under the
control of algD [38] and has another function as a requirement for
lipopolysaccharide (LPS) biosynthesis [39]. Thus downregulation of
algC would suggest defects in production of A band LPS in these
isolates.
Figure 2. Genotyping of P. aeruginosa AES-1R, AES-1M and
PAO1 by pulsed field gel electrophoresis. Bacterial cells embed-
ded in agarose plugs were lysed using EC lysis buffer (Sigma-Aldrich
Australia), and digested using restriction enzyme SpeI to generate a
small number (ca. 15–40) of large DNA fragments. Band patterns were
analysed using cluster analysis software (GelComparII
TM, Applied Maths,
Belgium) and established criteria [55] (same genotype if less than two
bands difference). The AES-1R and AES-1M genomes fall within these
criteria.
doi:10.1371/journal.pone.0024526.g002
Figure 3. Phenotypic appearance of P. aeruginosa AES-1R and
AES-1M in ASMDM at 72h. ASMDM was inoculated just under the
surface with 50ml of a 1:100 dilution of an overnight culture. Growing
cells were identified by oxidation of triphenyl tetrazolium chloride
(0.025% w/v final concentration) which stains cells a deep red colour.
doi:10.1371/journal.pone.0024526.g003
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of six enzymatic steps in the biosynthesis of uracil monophosphate
(UMP) from glutamine and aspartate precursors while uridylate
kinase pyrH (upregulated 6.4fold) catalyses the conversion of UMP
to UDP. Inhibition of the uracil biosynthetic pathway has been
demonstrated to repress biofilms and all three QS pathways (Rhl,
Las and Pqs) in P. aeruginosa [40] while Staphylococcus aureus pyrC
mutants showed a fivefold reduction in virulence in a BALB/c
mouse competitive systemic infection model and threefold in a
non-competitive systemic infection model [41]. Of the genes with
probable virulence roles upregulated in AES-1M, pel genes are
involved in P. aeruginosa biofilm formation [42] and enhance a
strain’s capacity to persist. Expression of pel genes by P. aeruginosa
has also been shown to competitively disrupt S. aureus biofilms [43].
The phospholipase C precursor plcN is important in extracellular
virulence as it degrades phosphatidylcholine, a constituent of lung
surfactant [44]. Cardiolipin synthase (cls) plays an important role
in membrane fluidity and P. putida cls mutants have shown
increased sensitivity to antibiotics [45].
Other genes upregulated in AES-1M included the putative
chemotactic transducer pctA (AES_5777 8.2fold) and a P. aeruginosa
pathogenicity island-1 (PAPI-1) gene (PA14-59980 5.6fold) also
found in UCBPP-PA14. PctA is essential for taxis towards sugars,
organic acids and L-amino-acids and in the acquisition of nitrogen
Table 2. Known virulence-related genes differentially expressed in P. aeruginosa AES-1M compared to AES-1R (p,0.05).
Gene name FC1 Description Role in P. aeruginosa
hemE 16.1 Uroporphyrinogen decarboxylase Regulation of alginate secretion
pyrC 12.1 Dihydroorotase Biofilm development, QS and virulence
pyrH 6.4 Uridylate kinase Biofilm development, QS and virulence
adhA 5.5 Alcohol dehydrogenase Required for biofilm development
pelB, pelE 5.6, 3.7 Extracellular polysaccharide Competitive disruption of S. aureus biofilms
cls 7.0 Cardiolipin synthase Increases membrane lipids and AB resistance
pscD 3.2 T3SS export protein Regulator of T3SS - virulence
plcN 3.2 Phospholipase C precursor Degrades phosphatidylcholine in lung surfactant
algD,E,F,8,amrZ 1.9-10.7 Alginate biosynthesis Biofilm development
ppiA 2.5 Peptidyl-prolyl cis-trans isomerase DppiA-decreased growth- susceptible to AB*
hmgA -7.2 Homogentisate 1-2-dioxygenase Loss induces pyomelanin - greater persistence
algC -9.3 Phosphomannomutase Loss = defective A band in lipopolysaccharide
1FC = Fold change - indicates up or downregulated in AES-1M relative to AES-1R.
*AB = Antibiotic.
doi:10.1371/journal.pone.0024526.t002
Figure 4. Differential expression of virulence-related genes by microarray and qPCR. Thirteen mainly virulence-related genes significantly
differentially expressed by microarray were also quantified for expression by qRT-PCR. Five of these (adhA, algC, AES_6147, AES_2005 and pyrC) were
quantified for qPCR using the same RNA sample as for microarray and eight (pelB, cls, algD. ppiA, pscD, hemE, pvcC and hmgA) were quantified using a
different RNA sample to that for microarray, and gave an overall correlation coefficient R
2=0.8053.
doi:10.1371/journal.pone.0024526.g004
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and their upregulation is of great interest due to the role of this
island in UCBPP-PA14 virulence [47] and its mode of spread to
CF strains [48].
Amongst genes downregulated in AES-1M, hmgA and thxA stand
out. Studies have shown loss of hmgA expression induces
pyomelanin production, which in turn leads to increased
persistence [49] and we have detected downregulation of HmgA
at the protein level in AES-1M. Thioredoxin has been shown to be
induced in P. aeruginosa PAO1 biofilms under strict anaerobic
conditions [50], yet in our studies P. aeruginosa grown in ASMDM
was unlikely to have experienced strictly anaerobic conditions as
both surface and subsurface growth has previously been shown to
have access to oxygen [24]. Thus AES-1R may be better able to
cope with hydrogen peroxide-mediated oxidative stress by
induction of the thioredoxin pathway, while chronic AES-1M
has adapted by not inducing the host cell-mediated response. Iron
uptake is critical in the iron-starved ASMDM and CF sputum
[24], thus the synthesis of the siderophores such as pyoverdine and
pyochelin would be expected to be high in both acute and chronic
isolates. Interestingly, in the pyoverdine biosynthesis operon
pvcABCD, pvcB was significantly upregulated (3.3fold) while pvcC
was significantly downregulated (27.5fold). A recent study
suggests pvcABCD is required not for pyoverdine production but
for dihydroxycumarin expression [51]. pvcAB makes an interme-
diate compound which is oxidized to the catechol form by pvcCD.
It is possible that the final product is not required by AES-1M,
leading to either mutation or downregulation of pvcC.
Hoboth et al. [23] compared an early mutator with an end-stage
non-mutator phenotype from the same patient, seeing a downreg-
ulation of virulence-related genes including T3SS, chemotaxis, QS
and flagellin genes. While that study did not use isogenic strains,
there are some findings in common with our study. Several
chemotaxis transducers (wspD, AES_2270 and AES_4899), and
T3SS genes (pcrV, pscC and pscI) were downregulated in AES-1M,
but most genes in these groups were not differentially expressed.
Mutation in any of the chemotaxis genes (wspABCDEF) leads to loss
of motility and auto-aggregation in P. aeruginosa [52]. Therefore the
downregulation of wspD suggests decreased motility and swarming,
possibly leading to less expansion and spread of biofilm microcol-
onies compared to AES-1R. Our phenotypic data (not shown)
demonstrate that AES-1M does swarm less than AES-1R, though
not significantly (Pearson’s x
2 test: p=0.062) however it swims and
twitches significantly more (p=0.29 and p=0.015, respectively).
With respect to expression of metabolic genes, only one TCA cycle
metabolism gene (isocitrate dehydrogenase-idh) downregulated in
the end-stage mutator [23], was also downregulated in AES-1M,
with the remainder not differentially expressed at p,0.05. Possible
reasons for the different metabolic profiles include growth media
and conditions, and AES-1-strain specific characteristics. Our study
used ASMDM, which resembles the composition of lung sputum,
and selected the entire biofilm (anaerobic and aerobic growth) for
analysis, compared to microaerobic growth in Luria-Bertani broth
used in the Hoboth study.
Conclusions
The sequencing of the AES-1 isolate AES-1R and the use of a
broad-capture array has for the first time enabled detection of the
expression of AES-1 genes not found in the reference strain PAO1.
Furthermore, the use of ASMDM has provided a profile of
differential expression of genes under sputum-like conditions. The
upregulation of certain virulence-related genes, including biofilm-
enhancing, competitive inhibition and persistence genes seen in
chronic AES-1M grown in ASMDM offers some explanation for
the spread and serious health outcomes associated clinically with
AES-1, including person-to-person transmission, more exacerba-
tions and more hospitalisations. In vivo analysis of knockout
mutants of differentially expressed genes in persister strains will aid
in identifying the factors leading to persistence.
Materials and Methods
Strains used in this study
Ethics approval for this study was given by the University of
Sydney Human Research Ethics Committee (Protocol Number:
X07-0029, Reference Number 6999). The Australian Epidemic
Strain-1 (AES-1, previously known as m16, C3789 or PI), is one of
two dominant eastern Australian mainland clonal complexes.
AES-1R was isolated from a child aged 14 months at the time as
the deaths of five CF-infants infected with AES-1 [53]. AES-1M
was isolated from the same patient at 11 years 9 months. AES-1
was not eradicated in the patient in the intervening period (D.
Armstrong pers. comm.). Written informed consent was obtained
by the Royal Children’s Hospital Melbourne, and The Southern
Health Service, Melbourne.
Genotyping of AES-1R and AES-1M
AES-1R and AES-1M were genotyped using pulse field gel
electrophoresis (PFGE) [54]. Briefly, bacterial cells embedded in
agarose plugs were lysed using EC lysis buffer (Sigma-Aldrich
Australia), and digested using restriction enzyme SpeI to generate a
small number (ca. 15–40) of large DNA fragments. After elec-
trophoresis of plugs containing digested DNA on 1.2% w/v agar,
band pattern analyses were performed using cluster analysis
software (GelComparII
TM, Applied Maths, Belgium) and the
criteria developed by Tenover et al [55] (different genotype if
more than a two band difference).
AES-1R genome sequencing and construction of the
PANarray
The AES-1R genome was sequenced using a 454 Genome
Sequencer GS20 (Roche Diagnostics, Basel, Switzerland). This
produced 598131 reads totalling 58 Mbp, providing approximate-
ly nine times coverage of the genome. De novo assembly using the
Newbler assembler with default parameters, produced 1968
contigs totalling 6.28 Mbp, which were ordered and oriented to
the P. aeruginosa PAO1 genome [56]. Putative genes were predicted
using GeneMarkS 4.6b [57]. The whole genome shotgun sequence
of the AES-1R genome (ID: 64619) is available at http://www.
ncbi.nlm.nih.gov/nuccore/AFNF00000000. To examine gene
homology amongst the eight P. aeruginosa genomes (AES-1R,
PAO1, PA7/PSPA7, PA14, PACS2, Pa_2192, Pae/PLES and
c3719), all gene protein sequences were clustered into orthologous
groups using OrthoMCL version 1.4 [58]. Genes were assigned an
origin based on the highest identity by BLAST analysis as
described on the web based annotation system for prokaryotes of
the Victorian Bioinformatics Consortium at Monash University
(WASABI) http://vbc.med.monash.edu.au/wasabi/. The AES-
1R genes, plus all those from the other seven P. aeruginosa genomes
were collated for input into the CombiMatrixH array design
software (CombiMatrix Corp. WA. USA). The resultant non-
redundant array contained 12,543 gene probe spots; comprising
12,147 P. aeruginosa gene probes (including 1,996 gene probes
spotted twice), 326 quality-control probes and 70 probes for non-P.
aeruginosa genes, including phage and plant genes. Lists of genes
unique to each PANarray genome (Table 1) were annotated based
on BLAST analysis results, with genes showing an E-value of less
than 10
24 designated as unique.
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ASMDM was prepared as described previously [24] and
triphenyl tetrazolium chloride to a final concentration of 0.025%
w/v was added to distinguish respiring cells. Ten milliliters of
ASMDM in 20 ml glass screw-cap bottles was inoculated with
50 ml of the diluted culture just under the surface of the media.
The cultures were incubated with a loose lid to permit gas
exchange at 37uC, and checked for growth every 24 h. ASMDM-
grown cells were harvested at 72 h. An uninoculated control was
included to detect media contamination.
Cell preparation and RNA extraction from ASMDM-grown
P. aeruginosa
Bacteria and associated biofilm material were removed from the
thick surface growth and the deep anaerobic projections at 72h
(Fig. 3) for RNA extraction. Cells were washed to increase cell
yield and remove debris. Briefly, the bacterial culture (ca. 10 ml)
was transferred to a 50 ml Falcon tube and washed 5 times in an
equal volume of ice-cold 16PBS or until the pellet was cleared of
non-cellular debris; by pelleting (5 min/5000 g/4uC), and re-
suspension in fresh ice-cold 16PBS. All steps were carried out on
ice or at 4uC to avoid cell and RNA degradation. Cells were
extracted for RNA as previously described [33].
cDNA synthesis and hybridization
cDNA was synthesized as previously described [59]. cDNA was
fragmented using DNaseI and quality-checked using a Bioanalyser
(Agilent, Germany). Chosen samples were KreaTech labelled
(Agilent) and then hybridized to the CombimatrixH PANarray at
the Australian Genome Research Facility (AGRF Ltd, Melbourne)
using Cy5 dye. Hybridization conditions were as previously
described [33,59].
Replicates for microarray analysis
AES-1R, AES-1M were arrayed as biological duplicates (same
isolate, different culture, different RNA extraction, and different
microarray) giving a total of four data sets, to assess biological
variability at the level of culture. Substitution of different biological
(culture) replicates was conducted for AES-1R to test for
variability, and these had little or no effect on the prediction of
differentially expressed genes.
Data analysis
The raw data were re-scaled to account for differences in
individual hybridization intensities. Background corrected data were
imported into Partek software, version 6.4 2010 (Partek Inc.), and
quantile normalisation (Bolstad et al, 2003) was carried out on the
fourAES-1 data sets. Data for each pair ofbiological duplicates were
averaged and the average of the acute and chronic isolates was used
to determine differential-expression. Genes that were differentially
expressed were determined by an ANOVA model with a cut-off
value of p=0.05. All microarray data is MIAME compliant and
both the raw and normalized data have been deposited in the
MIAME compliant database Gene Expression Omnibus (GEO)
http://www.ncbi.nlm.nih.gov/projects/geo under platform acces-
sion number GPL13324/Series GSE28152.
Gene expression by quantitative PCR
Thirteen genes mainly virulence-related genes that showed
significant differential expression by microarray (adhA, algC,
AES_6147, AES_2005, pyrC, pelB, cls, algD. ppiA, pscD, hemE, pvcC
and hmgA) were also checked for expression by quantitative SYBR-
green-PCR (qPCR) using a Rotor-Gene6000 Real-Time amplifi-
cation system (Qiagen), and performed on cDNA synthesised from
the microarray RNA or synthesised from RNA extracted from
later equivalent experiments. Genes were chosen based on high
differential expression and/or association with virulence (Tables 2
and 3). Oligonucleotide primers were designed using Primer
Express (Applied Biosystems). cDNA was synthesised as described
(Invitrogen), by reverse transcription (RT) using 50U Super-
ScriptII RT (Invitrogen) and 1 mg total RNA.
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